Contact this trialFirst, we need to learn more about you.
PD-1 Inhibitor
Pembrolizumab for Merkel Cell Carcinoma
Recruiting2 awardsPhase 3
New York, New York
This trial is testing a new cancer treatment called pembrolizumab in people with Merkel Cell Carcinoma who have not had treatment before. The goal is to see if it is effective and safe.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.